FLUCELVAX® Informational Flyer
Find out what makes FLUCELVAX® (Influenza Vaccine) different, including background on what impacts vaccine effectiveness, cell-based manufacturing technology, and age indication.
DownloadCPT=Current Procedural Terminology
![A flyer highlighting the features of FLUCELVAX (Influenza Vaccine)](/medias/2024-CSL-SEQIRUS-FLUCELVAX-Informational-Flyer.webp?context=bWFzdGVyfHJvb3R8MTMyOTB8YXBwbGljYXRpb24vb2N0ZXQtc3RyZWFtfGFHWmlMMmhqTUM4NE9EZ3pOamN5TkRFMk1qZzJMekl3TWpSZlExTk1YMU5GVVVsU1ZWTmZSa3hWUTBWTVZrRllYMGx1Wm05eWJXRjBhVzl1WVd4ZlJteDVaWEl1ZDJWaWNBfDZmY2JmM2UyMGFjOWU0NzlkNDMzYjA4MGUyM2RjMTMzZjM3YzZjNDA1ZmVlZDQ4MDQyMDdkNjRkOWMwMTNkYzU)
Resource Notes:
![Attributes Checklist](../_ui/responsive/theme-lambda/images/resources-check.png)
- Indicated for patients 6 months and older
- Explanation of cell-based technology
- Includes CPT codes and Important Safety Information